About Us
Our Approach & Focus
About microRNAs
Pipeline
Patients
Publications
News & Events
Contact
Contact Us
News & Events
News
October 25, 2022
Arthex Biotech Selected for EIC Accelerator Award of up to 14 Million Euros
July 20, 2022
ARTHEx Biotech announces ATX-01 has been granted Orphan Drug Designation by the FDA
June 6, 2022
ARTHEx biotech drug delivery Platform: Enhancing antimiR delivery to treat unmet diseases
January 17, 2022
It is competition time!
December 28, 2021
ARTHEx Biotech finishes the year 2021 met another key milestone in its investigational RNA treatment for DM1
September 20, 2021
La Agencia Valencia de la Innovación nos concede una ayuda para incorporar talento
September 14, 2021
Más cerca de los pacientes apoyando el Día Mundial de la Distrofia Miotónica
September 14, 2021
Closer to patients in support of International Myotonic Dystrophy Awareness Day
August 27, 2021
Take part in our survey on the occasion of the International Day of Awareness on Myotonic Dystrophy
Previous
Next
Events
October 30 - November 1, 2023
Tides Europe 2023
October 26 - 27, 2023
Spanish Meeting on Oligonucleotide Therapeutics (SMOT III)
October 22-25, 2023
19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
September 6–7, 2023
RNA Leaders USA Congress
May 7 – 10, 2023 | San Diego, CA USA
TIDES USA - Oligonucleotide & Peptide Therapeutics
November 16-18, 2022, Vienna
TIDES Europe
October 2-5,2022, Phoenix
18th Annual Meeting of the Oligonucleotide Therapeutics Society
September 9-10, 2022; San Diego
2022 MDF Annual Conference
Bassel. September 21-22, 2022
22ND ANNUAL BIOTECH IN EUROPE FORUM
October 17-18, 2023
3rd Annual Needham Private Biotech Company Virtual 1x1 Forum
